Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites

Preventive Medicine

Volumn 67, Issue , 2014, Pages 316-319

  Kharbanda, Elyse O ^a   Vazquez Benitez, Gabriela ^a   Lipkind, Heather ^b   Naleway, Allison L ^c   Klein, Nicola P ^d   Cheetham, T Craig ^d   Hambidge, Simon J ^d,e   Vellozzi, Claudia ^f   Nordin, James D ^a  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d KAISER PERMANENTE   (United States)

^e DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Pertussis; Pregnancy; Vaccine coverage

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVE BIRTH; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PREPREGNANCY CARE; PRIORITY JOURNAL; PUERPERIUM;

EID: 84904271933     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.05.025     Document Type: Article

References (20)

1. A.C.O.G. Committee Opinion No. 566, Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet. Gynecol. 121:6 (2013), 1411–1414 (Jun).
2. Ahluwalia, I.B., Jamieson, D.J., Rasmussen, S.A., D'Angelo, D., Goodman, D., Kim, H., Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet. Gynecol. 116:4 (2010), 949–955 (Oct).
3. Anon., Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 117:3 (2006), 965–978 (Mar).
4. Anon., Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb. Mortal. Wkly Rep. 60:41 (2011), 1424–1426 (Oct 21).
5. Anon., Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb. Mortal. Wkly Rep. 62:7 (2013), 131–135 (Feb 22).
6. Baggs, J., Gee, J., Lewis, E., et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 127:Suppl. 1 (2011), S45–S53 (May).
7. Broder, K.R., Cortese, M.M., Iskander, J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 55:RR-3 (2006), 1–34 (Mar 24).
8. CDC, Notes from the field: pertussis—California, January–June 2010. Morb. Mortal. Wkly. Rep., 59(26), 2010, 817.
9. CDPH, Broadens recommendations for vaccinating against pertussis: immunization key to controlling whooping cough. http://www.cdph.ca.gov/Pages/PH10-048.aspx (Accessed December 2, 2013).
10. Gall, S.A., Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants. Clin. Obstet. Gynecol. 55:2 (2012), 498–509 (Jun).
11. Henninger, M., Crane, B., Naleway, A., Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm. J. 17:2 (2013), 31–36 (Spring).
12. Kharbanda, E.O., Vazquez-Benitez, G., Shi, W.X., et al. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am. J. Obstet. Gynecol. 207:3 Suppl. (2012), S47–S51 (Sep).
13. Kharbanda, E.O., Vazquez-Benitez, G., Lipkind, H., Naleway, A., Lee, G., Nordin, J.D., Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet. Gynecol. 122:3 (2013), 659–667 (Sep).
14. Kretsinger, K., Broder, K.R., Cortese, M.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep. 55:RR-17 (2006), 1–37 (Dec 15).
15. Naleway, A.L., Gold, R., Kurosky, S., et al. Identifying pregnancy episodes, outcomes, and mother–infant pairs in the Vaccine Safety Datalink. Vaccine 31:27 (2013), 2898–2903.
16. Naleway, A.L., Kurosky, S., Henninger, M.L., et al. Vaccinations given during pregnancy, 2002–2009: a descriptive study. Am. J. Prev. Med. 46:2 (2014), 150–157 (Feb).
17. Nordin, J.D., Kharbanda, E.O., Benitez, G.V., et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet. Gynecol. 121:3 (2013), 519–525 (Mar).
18. Peters, T.R., Banks, G.C., Snively, B.M., Poehling, K.A., Potential impact of parental Tdap immunization on infant pertussis hospitalizations. Vaccine 30:37 (2012), 5527–5532.
19. Terranella, A., Asay, G.R., Messonnier, M.L., Clark, T.A., Liang, J.L., Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 131:6 (2013), e1748–e1756 (Jun).
20. Winter, K., Harriman, K., Zipprich, J., et al. California Pertussis Epidemic, 2010. J. Pediatr. 161:6 (2012), 1091–1096.